Concurrently, we will also be seeking shareholder approval

New Post Public Reply Private Reply Replies (2) Message Board
Djpele drugmanrx #20702
589
Quote:
Concurrently, we will also be seeking shareholder approval via a consent solicitation (the “Consent Solicitation”) for the filing of an amendment to our Articles of Incorporation (the “Certificate of Amendment”)......This will give us the ability to, among other things, raise additional capital so that we can continue to fund our operations and fulfill certain obligations that we have to investors.


No idea if they are referring to Pasaca, or any loan agreements that are outstanding. There is no mention of Innova/Pasaca anywhere.

Quote:
We have recently made significant reductions to our staff and our overhead. We have narrowed the company’s development and commercialization focus to only those technologies/products that we believe can achieve near-term commercial success or have a clear line of site to a commercial strategic partner.


What I see here is a company in dire straits. With no revenues, they are doing everything they can to stay above water.

Quote:
......We have expended considerable resources developing and marketing our HealthID product but have not yet achieved the anticipated success. Despite the substantial interest and verbal commitments, primarily from U.K.-centric companies, the wide-ranging extended shut down in the U.K. interfered with our ability to get the product adopted. Although we still believe QMC HealthID has great potential, we also think it has much more synergy with our quantum dot point of care testing technologies. We will also be seeking out potential strategic partners as well as potential acquirers for this platform. As a result, this product will not be part of our immediate commercialization efforts.


This right here, shows that potential revenues that was speculated from Innova do not exist/have not occurred. Sure, they "may" sell to Innova, but from how I personally read this update, the partnership between Pasaca/Innova is either in trouble, or no longer in effect, especially since Health ID is not part of their immediate plan. If the partnership with Innova were alive and well, there would be NO REASON to shelve QMC HealthID.

Quote:
Although we believe that we have many promising opportunities under development, our ability to continue as a going concern is dependent upon our ability to reverse negative operating trends, obtain revenue from operations, raise additional capital, and/or obtain debt financing. We are continuing our plan to further grow and expand operations and seek sources of capital to pay our contractual obligations as they come due. Management believes that its current operating strategy will provide the opportunity for us to continue as a going concern as long as we are able to obtain additional financing; however, there is no assurance this will occur. If adequate working capital is not available, we may be forced to curtail operations, which would cause you to lose your entire investment.


Self explanatory.

Drug brought up the positives, but quite frankly, I don't think they help in our current situation. We have been talking about the "what if's" and "the positives" for quite some time, only to end up revoked. If we do end up back on the market, I foresee massive dilution, no partnership, and a decrease in our investment. Now, I can be wrong in all of this, but this is what I personally think. We'll have to see what the Consent Solicitation shows.

I have 319,225 shares in this company, and I am starting to SERIOUSLY doubt whether or not I'll receive any net worth from them.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
My posts is of my opinion only. Please conduct your own Due Diligence; this is YOUR investment.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delta Marks 19 Years at COP With Bold New Initiatives

Updated Category News Views 62

Delta's Commitment to Global Sustainability Delta's name pops up yet again at the United Nations Climate Change Conference (COP31) in Antalya, Turkey, marking the company's 19th consecutive year of participation. They're mounting efforts to hit that "35×35" target, aiming for 35% electrification by 2035. This isn't just fluff and rhetoric—it’s Delta taking the lead...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Lululemon Faces Lawsuit Over Securities Violations Concerns

Updated Category News Views 0

Lululemon in Legal Crosshairs So, here's the scoop that's rocking the activewear world. Lululemon athletica inc. (NASDAQ: LULU) is finding itself in hot legal water. The DJS Law Group is sounding the alarm for investors following a securities violation lawsuit slapped on the company. We're talking about some heavy allegations of misleading maneuvers, with accusations...

Continue Reading
TURNSON: A New Twist in the Drinking Game Arena

Updated Category News Views 0

TURNSON Raises the Bar for Social Fun When was the last time a new drinking game actually turned heads? Well, meet TURNSON, the fresh contender coming out of a tiny town in Louisiana. Thanks to a couple of inventive minds, this game aims to redefine how adults bond at parties. It's got the ingredients to stir up some excitement at social gatherings, parties, and wherever...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 417

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Spatial Genomics Market Set for Major Expansion by 2031

Updated Category News Views 23

The Rise of Spatial Genomics You’ve got to hand it to the science behind spatial genomics and transcriptomics—this arena’s not just on a hot streak; it’s scorching. We’re staring down the barrel of a market raring to more than double in value, surging from a worth of USD 0.67 billion in 2026 straight to the big USD 1.23 billion in 2031. The CAGR that’s...

Continue Reading
Nutex Health Scores Top Workplace Honor in 2026

Updated Category News Views 95

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 214

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
California Credit Union's Toy Drive Brings Holiday Cheer

Updated Category News Views 0

California Credit Union Joins Forces for Holiday Toy Drive Alright, folks, here’s a story with a feel-good spin straight out of Glendale. California Credit Union is at it again, teaming up with the Los Angeles Boys & Girls Club to sprinkle some holiday magic on local kiddos and their families. Now, it’s the sixth year straight they’ve pulled off this toy drive...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 223

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Results in Lyell Immunopharma's Ronde-Cel Trial

Updated Category News Views 274

Exciting Developments from Lyell Immunopharma In a recent presentation at a major medical conference, Lyell Immunopharma, Inc. (NASDAQ: LYEL), showcased groundbreaking clinical data surrounding its innovative cancer therapy candidate, ronde-cel, designed specifically for patients suffering from large B-cell lymphoma (LBCL). Their findings reveal high rates of durable...

Continue Reading
United Imaging Appoints John Campbell to Lead Customer Success

Updated Category News Views 183

United Imaging Healthcare Embraces New Leadership United Imaging, a global leader in advanced medical imaging and radiotherapy solutions, is thrilled to announce that John Campbell has joined the team as the Vice President of Customer Success for North America. In this strategic role, Campbell will play a vital part in nurturing customer partnerships, driving service...

Continue Reading
Tuya Smart Launches Four AIoT Technology Engines for Developers

Updated Category News Views 292

Empowering Developers with New AIoT Technology Engines At the recent TUYA Global Developer Summit, Tuya Smart showcased its groundbreaking contributions to the Artificial Intelligence of Things (AIoT). This event marked an important milestone as Tuya introduced not just one, but four advanced technology engines designed specifically for developers. These engines are set...

Continue Reading
Sui Cryptocurrency Experiences Significant Price Decline

Updated Category News Views 26

Recent Decline in Sui Cryptocurrency's Value In the latest financial update, the cryptocurrency Sui has seen a decline of 4.87% within the last 24 hours, bringing its price down to $1.93. This downward trajectory has been consistent over the previous week as well, where Sui recorded a 10% loss, dropping from $2.09 to its current value. Such fluctuations are common in the...

Continue Reading
Record Sales Growth Expected from Komatsu Amid Challenges

Updated Category News Views 44

Komatsu Projects Record Sales Despite Industry Challenges In a recent earnings call, Komatsu Ltd (OTC: KMTUY), a leading global player in construction and mining equipment, presented its mixed financial results for the second quarter of fiscal 2024. The company reported a commendable year-on-year increase in net sales by 9.2%, amounting to JPY 1.082 trillion, marking a...

Continue Reading